Nephrogen
Curative gene therapies for kidney diseases
We're building curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
Active Founders
Founded:2020
Batch:Summer 2020
Team Size:1
Status:Active
Location:New York
Primary Partner:Jared Friedman